AIDS Research and Human RetrovirusesVol. 30, No. S1 Vaccine, Viral Latency, and CureAn HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected AdultsChristine M. Hay, Gregory J. Wilson, Marnie Elizaga, Sue Li, Nidhi Kochar, Mary Allen, Magdalena Sobieszczyk, Ian Frank, Nicole Frahm, Georgia D. Tomaras, Michael Egan, Michael Pensiero, John Eldridge, and NIAID HIV Vaccine Trials NetworkChristine M. HayUniversity of Rochester Medical Center, Rochester, NY, United StatesSearch for more papers by this author, Gregory J. WilsonVanderbilt University, Nashville, TN, United StatesSearch for more papers by this author, Marnie ElizagaFred Hutchinson Cancer Research Center, Seattle, WA, United StatesSearch for more papers by this author, Sue LiSCHARP - FHCRC, Seattle, WA, United StatesSearch for more papers by this author, Nidhi KocharSCHARP - FHCRC, Seattle, WA, United StatesSearch for more papers by this author, Mary AllenDAIDS/NIAID/NIH, Rockville, MD, United StatesSearch for more papers by this author, Magdalena SobieszczykColumbia University, New York, NY, United StatesSearch for more papers by this author, Ian FrankUniversity of Pennsylvania, Philadelphia, NY, United StatesSearch for more papers by this author, Nicole FrahmFred Hutchinson Cancer Research Center, Seattle, WA, United StatesSearch for more papers by this author, Georgia D. TomarasDuke University, Durham, NC, United StatesSearch for more papers by this author, Michael EganProfectus Biosciences, Tarrytown, NY, United StatesSearch for more papers by this author, Michael PensieroDAIDS/NIAID/NIH, Rockville, MD, United StatesSearch for more papers by this author, John EldridgeProfectus Biosciences, Tarrytown, NY, United StatesSearch for more papers by this author, and NIAID HIV Vaccine Trials NetworkSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5019.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults." AIDS Research and Human Retroviruses, 30(S1), p. A17FiguresReferencesRelatedDetailsCited byFirst-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)5 June 2015 | Open Forum Infectious Diseases, Vol. 2, No. 3A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults7 August 2015 | PLOS ONE, Vol. 10, No. 8 Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Christine M. Hay, Gregory J. Wilson, Marnie Elizaga, Sue Li, Nidhi Kochar, Mary Allen, Magdalena Sobieszczyk, Ian Frank, Nicole Frahm, Georgia D. Tomaras, Michael Egan, Michael Pensiero, John Eldridge, and NIAID HIV Vaccine Trials Network.An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults.AIDS Research and Human Retroviruses.Oct 2014.A17-A17.http://doi.org/10.1089/aid.2014.5019.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download